Device Sectors
Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
August 5, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsIRVINE, California , and AMSTERDAM , August 5, 2010 /- Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington...
In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Ne...
August 5, 2010 5:36 am | by Bio-Medicine.Org | News | CommentsWALTHAM, Mass. , Aug. 5 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection (CDI), nearly 70 percent of surveyed infectious disease...
Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results
August 5, 2010 5:36 am | by Bio-Medicine.Org | News | CommentsBEIJING , Aug. 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading developer and provider of vaccines in China , announced today that it will release its financial results for the second quarter ended June 30, 2010 before the open of the market on Monday, August 16, 2010...
Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter
August 5, 2010 5:33 am | by Bio-Medicine.Org | News | CommentsCHICAGO , Aug. 5 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the...
ActiveHealth and IBM Pioneer Cloud Computing Approach to Help Doctors Deliver High Quality, Cost Effective Patient Care
August 5, 2010 4:36 am | by IBM | News | CommentsIBM (NYSE: IBM) and ActiveHealth Management, an Aetna (NYSE: AET) subsidiary, today unveiled a new cloud computing and clinical decision support solution that will enable medical practices, hospitals and states to change the way they deliver healthcare, providing better quality care at a...
Genzyme patients call for competitor access to drug patent
August 5, 2010 12:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsThree patients taking Genzyme Corp.'s drug for Fabry disease, Fabrazyme, have petitioned the U.S. Department of Health and Human Services to use a rarely-used legal maneuver to open up the drug to competition.
PCR test developed by BCM identifies elephant herpes virus
August 4, 2010 12:35 pm | by Baylor College of Medicine | News | CommentsA sensitive real-time PCR test that specifically detects a deadly strain of herpes virus in elephants has been developed by researchers at Baylor College of Medicine. The findings appear in the current edition of the American Journal of Veterinary Research . There are many strains of...
Pascal Metrics Welcomes Jim Conway to Leadership Team as Principal
August 4, 2010 11:38 am | by Bio-Medicine.Org | News | CommentsWASHINGTON , Aug. 4 /- Pascal Metrics is delighted to announce the appointment of Jim Conway as Principal leading its Governance and Leadership Group, effective immediately. The newly formed Governance & Leadership Group advises boards of directors and senior executive leaders...
Landau Uniforms Donates $600,000 in Scrubs to Haiti Relief
August 4, 2010 11:38 am | by Bio-Medicine.Org | News | CommentsMEMPHIS, Tenn. , Aug. 4 /- Landau Uniforms, the nation's leading quality health care apparel manufacturer, has donated more than $600,000 worth of scrubs to aid Haiti relief efforts. "Landau is committed to providing ongoing, long-term support for Haiti as it struggles to recover from...
Daiichi Sankyo Settled Patent Litigation for Evoxac®
August 4, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsPARSIPPANY, N.J. , Aug. 4 /- Daiichi Sankyo, Inc. and its parent company, Daiichi Sankyo Co., Ltd, (collectively, "Daiichi Sankyo") have reached an agreement with Apotex Inc. and Apotex Corp. (collectively, "Apotex") to settle their patent litigation involving Apotex's challenge to...
OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research
August 4, 2010 11:34 am | by Bio-Medicine.Org | News | CommentsIRVINE, Calif. , Aug. 4 /- OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, is pleased to announce their partnership with The Gynecologic Oncology Group (GOG) through the...
UT Southwestern's cancer center earns National Cancer Institute designation
August 4, 2010 10:34 am | by EurekAlert | News | Comments(UT Southwestern Medical Center) The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained National Cancer Institute designation, an elite distinction held by only 65 other cancer centers nationwide.
Parents should help teens get back on right sleep track
August 4, 2010 10:34 am | by Baylor College of Medicine | News | CommentsComputers, televisions and cell phones are preventing your teen from getting enough sleep, and that can affect grades and day to day life, said a sleep expert at Baylor College of Medicine . "Because teens tend to stay up and wake up later in the summer, their bodies get used to it,...
Tolerx names biotech vet de Fougerolles to chief scientist
August 4, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | CommentsTolerx Inc. has appointed Antonin de Fougerolles as chief scientific officer of the cancer, diabetes and autoimmune disease therapeutics firm. His role includeds overseeing the company's research and development and growing Tolerx's leadership in T cell immunology.
Gene for Cholesterol and Cardiovascular Disease Identified through Genome Scan
August 4, 2010 9:35 am | by University Of Pennsylvania | News | CommentsResearchers have shown that a gene linked to a disease trait by genome wide association studies (GWAS) can be clinically relevant and an important determinant of disease risk. In a study published this week in Nature, a team of investigators describes how a region on chromosome 1...
Technology transfer: 25 years at Baylor College of Medicine
August 4, 2010 9:33 am | by Baylor College of Medicine | News | CommentsThe Baylor Licensing Group – the office responsible for transferring research results and discoveries developed by Baylor College of Medicine faculty to the marketplace – is celebrating 25 years at the College. More than 200 diagnostic, clinical and research products have...
Health Robotics Continues to Dominate I.V. Automation in America, With 11 New Contracts in Second Quarter 2010
August 4, 2010 7:35 am | by Bio-Medicine.Org | News | CommentsBOZEN, SUD-TIROL, Italy , August 4, 2010 /- Health Robotics announced its second consecutive quarter's record-breaking results, as reported by our sales channel partner Health Robotics Canada Inc. (HRCI) since Health Robotics S.r.l. upgraded its American distribution channels this year....
Delcath to Present at the 30th Annual Canaccord Global Growth Conference
August 4, 2010 7:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK , Aug. 4 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that management will present at the 30th Annual Canaccord Global Growth Conference in Boston, MA on Thursday, August 12, 2010 at 8:30 a.m. ET . Mr. Eamonn Hobbs , Chief Executive Officer, and Mr. David...
Cardica to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results on Tuesday, August 17, 2010
August 4, 2010 7:34 am | by Bio-Medicine.Org | News | CommentsREDWOOD CITY, Calif. , Aug. 4 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that it will release financial results for its fiscal fourth quarter and year ended June 30, 2010 , on Tuesday, August 17, 2010 , after the markets close. Cardica's management will host a conference call at...
CardioTec Conference to Address Opportunities and Challenges in Cardiovascular Device Manufacturing
August 4, 2010 7:34 am | by Bio-Medicine.Org | News | CommentsRAMSEY, N.J. , Aug. 4 /- CardioTec is the first and only conference dedicated to addressing the challenges facing the cardiovascular device manufacturing industry. Hosted by Medical Product Outsourcing magazine, CardioTec invites OEM professionals and contract manufacturers/suppliers to...
PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis
August 4, 2010 7:34 am | by Bio-Medicine.Org | News | CommentsWHIPPANY, N.J. , Aug. 4 /- PolyGel® is proud to announce that their ThermoActive ™ Cold & Hot Mobile Compression Shoulder Orthosis has been SADMERC – approved for L-Code L3670. (Photo: http://photos.prnewswire.com/prnh/20100804/NY45060 ) (Photo: http://w...
China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment
August 4, 2010 2:36 am | by Bio-Medicine.Org | News | CommentsSHENZHEN, China , Aug. 4 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the State Administration of Foreign...
Detecting Concussion on the Football Field
August 3, 2010 8:34 pm | by Massachusetts Institute of Technology | News | CommentsNew device shows that brain injury may linger even after obvious symptoms disappear.
Invivo Wins Medical Design Excellence Award for Prostate Solutions
August 3, 2010 4:36 pm | by Bio-Medicine.Org | News | CommentsPEWAUKEE, Wis. , Aug. 3 /- On June 9, 2010 , Invivo was recognized with a 2010 Gold Medical Design Excellence Award (MDEA) for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City 's...
InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
August 3, 2010 10:37 am | by Bio-Medicine.Org | News | CommentsHUNTSVILLE, Ala. and MARLBOROUGH, Mass. , Aug. 3 /- InQ Biosciences Corporation , a provider of innovative technologies for cell growth and research, announced the appointment of John Ryder as Senior Vice President, Sales and Marketing. Ryder will be based in InQ's sales office in...
